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3IMM Project Goals
• To develop an integrated, quantified, 
evidence-based decision support tool 
useful to crew health and mission 
planners.
• To help align science, technology, and 
operational activities intended to 
optimize crew health, safety, and 
mission success.
4Scope and Approach
• Scope
• Forecast medical outcomes for in-flight operations only
• Forecast medical impacts to mission
• Does not assess long-term or chronic post-mission 
medical consequences
• Approach
• Use ISS data as stepping stone to Exploration Program
• Employ best-evidence clinical research methods
• Employ Probability Risk Assessment (PRA) techniques
• Collaborate with other NASA Centers and Organizations
IMM addresses in-flight risk only, and uses ISS data as stepping stone
5What is IMM?
• A software-based decision support tool 
• Forecasts the impact of medical events on 
space flight missions
• Optimizes the medical system within the 
constraints of the space flight environment 
during simulations.
6Software Technology
• Crystal Ball Software (Oracle Corp.)
• Commercially available software application 
• Microsoft Excel user interface 
• Stochastic forecasting and optimization
• SAS (Statistical Analysis Software)
• IMM 1.0 currently transitioning to SAS due to 
large number of variables in the model
Software is used across a wide range of industries to represent 
stochastic, probabilistic processes and uncertainty
7HSI and Program Benefits
• How does a decision support tool like IMM 
aid a Program that’s just forming?
• Knowledge Management
• Objectivity
• Prioritization
• Rationalization
• Optimization
• Communication
8Who can benefit from IMM capabilities?
• Flight Surgeons
• What in-flight medical threats are greatest for reference mission A?
• Risk Managers
• What is the risk of evacuation - due to a medical event - for a 6-person, 
180 day mission assuming the current in-flight medical capability?
• Vehicle Designers
• What’s the optimum medical mass allocation for given level of risk?
• Health Care System Designers
• What medical items do we fly for a given mass/volume allocation?
• Trainers
• How do I prioritize limited crew training hours?
• Requirement Managers
• What’s the rationale for this crew health requirement?
9“What if…?” Questions
• Questions
• Is the current ISS medical kit adequate for a crew of 6 on a 
6-month mission?
• Does a 33-day lunar sortie mission require a different Level 
of Care than a 24-day lunar sortie mission?
• Are we carrying enough Ibuprofen for a crew of six on a 12-
month mission?
• How does risk change if the ventilator fails at the start of a 3-
year mission?
• Questions
• What is the probability of a bone fracture occurring 10-years 
after a 6-month mission?
• What is the probability of renal stone formation after a 12-
month mission?
IMM is designed to help answer specific in-flight questions
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When does IMM prove useful?
IMM supports decisions at all program phases
SSR
PDR
CDR
11
IMM Usage History
• IMM Inputs
• Rationale for ISS Medical Kit Redesign
• List of Prioritized Medical Conditions by 
Reference Mission
• Requirements rationale for vomitus and 
diarrhea  
• IMM Outputs
• ISS Risk Model Medical Updates - Pending
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Risk Vocabulary
Common Risk 
Management Terms
IMM
• Hazard
• Threat
• Initiating event
• Medical condition experienced 
by the crew in flight
• Likelihood • Probability of a medical event
• Consequence
• Outcome
• End State
• Evacuation
• Loss of Crew Life
• Crew Health Index (CHI)
• Control
• Mitigation
• In-flight capability to diagnose 
and treat the medical event
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Risk and Risk Components
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5x5 Matrix for Threat Z
RiskRisk
5x5 Matrix IMM
Likelihood 
(Score 1-5)
Medical 
Condition 
Incidence
Mitigation? In-flight Medical 
Capabilities
Outcome 
(Score 1-5)
Crew Functional 
Impairment
Risk Score (2x1) 
for a single “risk”
Impact to mission 
due to all medical 
conditions for the 
crew compliment
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“Risk” is what’s left over after you’ve accounted for likelihood, 
outcome, and the mitigation associated with the threat. 
14
IMM Conceptual Model
INPUTS
 Medical 
Conditions & 
Incidence Data
 Crew Profile
 Mission Profile & 
Constraints
 Potential Crew 
Impairments
 Potential Mission 
End states
 In-flight Medical 
Resources
Integrated
Medical
Model
OUTPUTS
 Medical Condition 
Occurrences
 Crew Impairments
 Clinical End States
 Mission End States
 Resource Utilization
 Optimized Medical 
System
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Comparison – 5x5 Risk Matrix vs. IMM
Integrated
Medical
Model
Medical Conditions & 
Incidence Data
Crew Profile
Mission Profile & Constraints
Crew Functional 
Impairments
 In-flight Medical Resources
Medical Condition Occurrences
Crew Impairment &         
Clinical End States
Resource Utilization
Optimization of Vehicle 
Constraints and Medical 
System Capabilities
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• Categorical
• Subjective
• Single Risk
• No Uncertainty
• No Confidence Interval
• Limited context
• Quantitative
• Probabilistic, Stochastic
• Evidence-based
• Integrated Risks
• Uncertainty
• Confidence Interval
• In context
5x5 Matrix IMM
Risk
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IMM Logic
INPUTS
 Medical Conditions & 
Incidence Data
 Crew Profile
 Mission Profile & Constraints
 Potential Crew Functional 
Impairments
 Potential Mission End States
 In-flight Medical Resources
IMM
OUTPUT of Distributions
 Medical Condition Occurrences
 Crew Impairment
 Clinical End States
 Mission End States
 Resource Utilization
 Optimized Medical System
Best-Case Scenario
Worst-case Scenario
Untreated Scenario- Best Case
Medical 
Conditions
Occur?
All 
Resource
sAvailabl
e?
Available Resources 
Decremented
No
YesYes
A simulation set may include 5-25,000 trial missions
Untreated Scenario- Worst-Case
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IMM Logic
1. Did the medical condition happen?
2. How many times?
3. Best or worst-case scenario?
4. Were resources available?
5. What was the outcome? 1
2
3
4
5
For each comparative assessment, the identical questions 
are asked 5,000+ times to develop outcome distributions
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Key Development Steps
• Develop a Conceptual Model
• Create initial list of relevant medical conditions
• Characterize incidence data
• Quantify crew impairment and clinical end states
• Quantify resources needed to diagnose and treat
• Develop a quantified Crew Health Index
• Understand implications of assumptions
• Verify & Validate
• Refine & Maintain Data
Each step is in the critical path 
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Development Status
• Current Status of Model
• First version of IMM 1.0 completed (Sept 2008)
• IMM 1.0 supports assessments of 1-6 crew members
• 83 medical conditions represented
• 47 of 83 medical conditions have been recorded to occur in flight
• Medical Resources (type, quantity, mass, volume) per condition
• Capabilities
• Forecasts medical condition occurrences
• Identifies medical conditions that most influence crew 
impairment and mission impact
• Identifies key contributors to crew impairment and clinical 
outcomes (e.g. depleted or lack of in-flight medical resources)
• Compares crew health risk between different missions
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IMM Development vs. Constellation Program Schedule
PMR ’08 Rev 1 – As of 03/31/09
Flight Plan
FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16
Ares I / Orion Launches
Program 
Integration
Today
PDR 1SRR CDR SDR
PPAR PAR (NET)
Orion 1 Orion 3 Orion 5
Orion 6
Orion 7
Orion 8Orion 2 Orion 4
Full Operational Capability 
Orion
SRR SDR PDR
DDT&E
CDR DCR
PDR 2 SAR
SRR PDR CDR
DDT&E
Project ATP
Production
Altair
IMM
IM
M
 1
.0
Proof of Concept/Prototype Alpha
IM
M
 2
.0
ProductionBeta
IM
M
 3
.0
IMM Transition to Operations
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Next Steps
• Work in Progress
• Transition to SAS software platform
• Optimization Algorithm Implementation
• Database Development & Integration
• Internal Verification & Validation
• Next 12 Months – Key Milestones
• Develop database user interfaces
• Develop IMM 2.0
• Initiate external Verification & Validation
• Communication to stakeholders
• Prepare for transition to operations
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Closing
(Source: NASA Return to Flight Task Group Final Report: Annex A.2 
Individual Member Observations by Dr. Dan L. Crippen, Dr. Charles C. 
Daniel, Dr. Amy K. Donahue, Col. Susan J. Helms, Ms. Susan Morrisey 
Livingstone, Dr. Rosemary O'Leary, and Mr. William Wegner.)
…experience and instinct are poor substitutes for 
careful analysis of uncertainty…
…This requires that analytical models be used 
appropriately to inform decisions…
IMM addresses the observations documented by the RTF Task Group
IMM Clinical Methods and Inputs
Presenter: Eric Kerstman M.D., M.P.H.
ekerstman@wylehou.com
(281) 212 - 1305
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IMM Clinical Inputs
Outline
• Development of the Medical Condition List (MCL)
• Overview of Incidence Determinations
• Functional Impairments
• Clinical Findings Form (CliFF)
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Medical Clinical Inputs
Purpose
• To provide a list of medical conditions relevant to in-flight 
operations
Relevant Medical Condition
• Has occurred in flight or has the potential to occur in flight
• Requires mitigation and/or results in functional impairment
Current Status
• Consists of 83 medical conditions (47 have occurred in flight)
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Development of the Medical Condition List
• MCL Phase I
• ISS Medical Checklist (70 conditions)
• MCL Phase II
• STS Medical Checklist (+1)
• MCL Phase III
• Longitudinal Study of Astronaut Health (LSAH)   
In-flight Medical Condition Occurrences (+6)
• MCL Phase IV
• Flight Surgeon Delphi Study (+6)
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MCL Phase III
LSAH
In flight Medical Condition Occurrences
• Includes Apollo, Skylab, Mir, Shuttle, and ISS
• STS-1 through STS-114 in 2005
• Expedition 1 through Expedition 13 in 2006
• 47 relevant medical conditions
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The Use of Incidence
• Incidence is a measure of the likelihood of 
developing a medical condition
• IMM uses incidence to quantify the likelihood
of occurrence of medical conditions in flight
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Incidence Definitions
The number of new medical events that occur 
within a specified time period
Incidence Proportion (Cumulative Incidence)
• The proportion of a population who develop a medical condition 
within a specified period of time (events/person)
Incidence Rate (Incidence Density)
• The number of new medical events that occur within a 
population divided by the total time the population was at risk 
(events/person-year)
• Accounts for the different times that each individual was at risk
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IMM Classification of Medical Conditions
Space Adaptation Syndrome (SAS)
Non-Space Adaptation Syndrome
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SAS Medical Conditions
1) Back Pain
2) Constipation
3) Headache 
4) Insomnia
5) Nasal Congestion
6) Nosebleed
7) Space Motion Sickness
8) Urinary Incontinence
9) Urinary Retention
32
Space Adaptation Syndrome Medical Conditions
• Likelihood of occurrence is not related to 
mission duration
• Condition does not recur
• Incidence proportions (events/person)     
are determined from LSAH in flight 
occurrence data
Example: Nasal Congestion
405 events among 660 persons = 0.614 events/person
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Non-SAS Medical Conditions
• The likelihood of occurrence is related to 
mission duration
• Condition may recur
• Incidence rates (events/person-year) are 
determined from LSAH in flight occurrence 
data or other sources
Example: Skin Rash
90 events within 27.34 person-years = 3.29 events/person-year
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Non-Space Adaptation Syndrome Medical Conditions
Incidence Rate Determinations
Conditions that have occurred in flight
• LSAH in flight occurrence data 
Conditions that have not occurred in flight
• External models (fractures)
• Environmental engineering data (altitude sickness)
• Terrestrial general/analog population data 
(appendicitis)
• Bayesian statistics for rare events (kidney stones)
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The Use of Functional Impairments
IMM uses the concept of functional impairments to 
quantify the severity of medical condition outcomes
Outcome
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Impairment
• A loss or loss of use of a body part, 
organ system, or organ function
• Considers both anatomic and 
functional loss
• Can develop from an illness or injury
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American Medical Association Guides to the 
Evaluation of Permanent Impairment
Impairments
• Percentages that reflect the severity of the medical condition
• No impairment = 0 percent
• Fully dependant/approaching death = 100 percent
Examples
Skin Infection = 10 to 24 percent impairment
Shoulder Dislocation = 36 to 74 percent impairment
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Clinical Findings Form (CliFF)
Standardized Format for IMM Clinical Inputs
The likelihood of occurrence of the medical condition
• Incidence proportion or incidence rate
The clinical outcomes of the medical condition
• Considers ISS-based best case, worst case, and untreated 
case scenarios
• Specifies functional impairments and duration times
• Specifies potential end states (evacuation, loss of crew life)
• Specifies levels of evidence for input data
• References sources of data
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Summary
• Relevant list of medical conditions 
established 
• Incidence data established for each medical 
conditions 
• Crew functional impairments and end states 
(evacuation and loss of crew life) used to 
characterize impact due to medical events 
• Standardized tool (CliFF) established for 
clinical inputs of likelihood and outcomes for 
each medical condition
In-flight Diagnosis & 
Treatment Resources
Presenter: Lynn Saile
lsaile@wylehou.com
(281) 212 -1488
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Resource Tables
• Specifies the necessary 
resources for diagnosis 
• Considers the treatment of best
and worst case scenarios
• Provides input into IMM
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The resource tables (RT) define the 
in-flight medical resources
41
Best and Worst Cases
Consumable Disorder: Musculoskeletal Description Quantity
Power 
(W)
Cost 
Estimates  COTS 
Flight 
Certify
Sustaining 
Eng
1 Sprain/Strain Extremities Ace Bandage 1 0.03875 38.75 442.5 442500  $       3.08 
SAM splint 1 0.1134 113.4 1336.3575 1336357.5  $     12.00 
1 Acetaminophen 2 0.00036 0.36 0.02632 26.32  $       0.10 
1 Ibuprofen 1-9 0.00066 0.66 0.04202 42.02  $       0.14 
        Mass
   Kg           Gm
          Volume 
       cc3          mm3
Mass
Kg    M
Volume
cc3              mm3
Consumable COTSQuantity
Consumable Disorder Description Quantity Power Cost Estimates  COTS 
Flight 
Certify
Sustaining 
Eng
Sprain/Strain 
Extremities Ace Bandage 1 0.03875 38.75 442.5000 442500  $       3.08 
SAM splint 1 0.1134 113.4 1336.3575 1336357.5  $     12.00 
1
acetaminophen (2 tabs*4-
6hr) 8 0.00036 0.36 0.0263 26.32  $       0.10 
1 ibuprofen (1-2 tabs*8hr) 10 0.00066 0.66 0.0420 42.02  $       0.14 
1 Vicodin (1-2 tabs *4-6 hr) 2 0.00064 0.64 0.0483 48.30 0.50$        
1 Gauze Pads 4 0.00504 5.04 7.6000 7600.00 0.16$        
1 Nonsterile Gloves pr 1 0.014 14 3.1000 3100 0.10$        
Sharps container 1 0.59553 595.53 2909.1250 2909125.00 817.06$      
1 20 G catheter 2 0.00622 18.51 7.5000 7500 0.15$        
1 10cc syringe 1 0.01123 11.23 4.1700 4170 0.15$        
1 Y-type catheter 1 0.00868 8.68 0.1000 100.00 0.50$        
1 Tegaderm Dressing 1 0.00252 2.52 108.2000 108200 0.38$        
1 Saline, 500mL 1 0.48929 489.29 750.8390 750839.00 10.81$      
1 Iodine Pads 1 0.00108 1.08 0.1500 150.00 0.04$        
1 Alcohol Pads 12 0.00108 1.08 0.1500 150.00 0.02$        
1 Tourniquet 1 0.00603 6.03 5.0000 5000 0.24$        
1 Tape 0.1 0.00906 9.06 6.4220 6422.00 0.11$        
1 Morphine  1-10ml 0.00795 7.95 6.8855 6885.53  $     21.50 
1 carpuject 1 0.01524 15.24 5.6267 5626.67 5.01$        
Mass
Kg            Gm
Volume 
cc3          mm3
Best Case Scenario
Worst Case Scenario
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Resource Table Assumptions
• The resource tables reflect the current ISS 
medical equipment, supplies, drugs, etc.
• Conditions go “untreated” when an 
“essential” item is not available (due to 
depletion or omission from the health care 
system)
• Cost information only includes Commercial-
off-the-shelf (COTS)
• Spacecraft resources (e.g. oxygen, water, 
power, bandwidth) are not constrained
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In-flight Mitigation
• Medical resources 
can be optimized for 
specific missions and 
crew profiles
• Resource tables 
identify the necessary 
supplies to mitigate 
risk by improving 
medical outcomes
54321
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Integrated Medical Model
Outputs and Simulated Mission Scenarios
Presenter: Charles G. Minard, PhD
charles.g.minard@nasa.gov
281-461-2774
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Integrated Medical Model
“Essentially, all models are wrong, but some 
are useful.”
George Box (1987)
Professor Emeritus of Statistics at the 
University of Wisconsin
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Statistical Methods
• IMM uses Monte Carlo simulation
• Crystal Ball software
• Microsoft Excel
• Distribution of outcomes
• Probability distributions
• Beta, Beta-PERT, Poisson, Bernoulli, Binomial, 
Lognormal, Uniform, Discrete uniform
• Crew Health Index (CHI)
• Quality-adjusted mission time
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Quality-Adjusted Mission Time
• Modification of quality-adjusted life 
years (QALY)
• Standard epidemiologic measure
• Single, weighted measure of the net 
change in quality time
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Example of QALY
• Consider the following individual:
• 35 years old
• 75 year life expectancy
• Medical event results in 30% functional impairment
• Below knee amputation
• What is the QALY?
• With respect to IMM, “Life” is mission time
( )
%70%100
40
28
yrs 2812403.04040
=⋅=
=−=−=
PQALY
QALY Crew Health 
Index (CHI)
49
Crew Health Index (CHI)
• Measure of crew performance
• Ranges from 0 to 100%
• 0% - completely impaired due to medical 
conditions for duration of mission
• 100% - no impairment due to medical 
conditions
50
Key Model Assumptions
• 83 medical conditions
• ISS Health Maintenance System (HMS)
• Conservative estimate of Crew Health 
Index (CHI)
• Medical events assumed to occur on the 
first day of the mission
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6 Month Mission
• Is the current HMS adequate for a 6 
member crew?
• Consider two alternative 6 month missions
• 3 crew members (2M,1F)
• 6 crew members (5M,1F)
• 2 EVAs per crew member
• Identical medical resources (ISS)
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Total Medical Events (3 Crew)
53
Total Medical Events (6 Crew)
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Total Medical Events
• Expect about twice 
as many medical 
events
• Expect greater 
variation in the 
number of events
Statistic 3 Crew 6 Crew
Mean 45.6 91.2
Median 46.0 91.0
SD 6.6 9.3
95% Inf. 34-59 73-110
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Sensitivity Analysis
• What are the most influential factors?
• Which variables describe the greatest 
variation in the distribution of the outcome?
• Which variables are most highly correlated 
with the outcome of interest?
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Sensitivity Analysis – Total Events
3 Crew Members 6 Crew Members
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Sensitivity Analysis – Total Events
3 Crew Members
1) Late insomnia
2) Skin rash
3) Skin abrasion/laceration
4) Corneal abrasion
6 Crew Members
1) Late insomnia
2) Skin rash
3) Skin abrasion/laceration
4) Corneal abrasion
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Crew Health Index (3 Crew)
59
Crew Health Index (6 Crew)
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Crew Health Index
• Expect decreased CHI with 
6 crew members
• Expect greater variation
Statistic 3 Crew 6 Crew
Mean 84.8 65.3
Median 89.5 67.0
SD 13.0 17.6
95% Inference 51-98 28-93
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CHI Sensitivity Analysis
3 Crew Members
1) Skin rash
2) Cough
6 Crew Members
1) Skin rash
2) Paresthesia
Why was the CHI decreased for 6 crew members?
• Consider medical resources for skin rash
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Skin Rash Resources (3 Crew)
63
Skin Rash Resources (6 Crew)
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Lotramin AF
3 Crew Members
6 Crew Members
Insufficient for 13.3% 
of the trials
Insufficient for 76.0% of 
the trials
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Summary
• Is the current ISS HMS adequate for a 6 
member crew?
• Substantial decrease in CHI with three additional 
crew members
• What conditions had the greatest impact?
• Skin rash
• Paresthesia
• Corneal abrasions
• Why did skin rash impact the CHI?
• Insufficient medical resources
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Alternative Analyses
• Examine specific medical resources
• Ibuprofen
• Alternative resource allocation
• Increase supply for 6 crew, 6 month mission
• Shorter missions
• 24 versus 33 day missions
• Vary number of crew members
• 3 crew versus 4 crew
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Alternative Outcomes
• Probability of evacuation
• Probability of loss of crew life
• Summary measures that combines CHI, 
EVAC, and LOCL?
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Probability of EVAC
Information has not been validated.
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Summary
• IMM is a tool to assist in the decision 
making process
• It does not make decisions
• IMM provides an objective analysis of 
likely medical events and outcomes 
during space flight
• IMM provides comparative analyses
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Questions?
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Skin Abrasion/Laceration Resources
(3 Crew: Best Case only)
72
Skin Abrasion/Laceration Resources
(6 Crew: Best Case only)
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Gauze Pads
3 Crew Members
6 Crew Members
Insufficient for 0.6% 
of the trials
Insufficient for 41.9% 
of the trials
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Povidone Iodine Swabs
3 Crew Members
6 Crew Members
Insufficient for 4.8% of 
the trials
Insufficient for 59.5% of 
the trials
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Ibuprofen
• Compare Ibuprofen use
• 3 crew, 6 months
• 6 crew, 6 months
• What medical conditions explain the 
Ibuprofen usage?
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Ibuprofen (6 Month Mission)
3 Crew Members
6 Crew Members
Insufficient for 2.0% of 
the trials
Insufficient for 45.0% of 
the trials
77
Ibuprofen Sensitivity Analysis
3 Crew Members
1) Back injury
2) Sprain/Strain - Shoulder
3) Paresthesia
4) Back pain (SAS)
5) Sprain/Strain – Elbow
6 Crew Members
1) Back injury
2) Sprain/Strain - Shoulder
3) Paresthesia
4) Back pain (SAS)
5) Sprain/Strain – Elbow
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Increase Medical Resource Supply
• Will increasing the medical supplies increase the 
Crew Health Index?
• Double these resources for 6 crew member mission
• Gauze pads
• Povidone iodine swabs
• Benadryl capsules
• Ibuprofen
• Increases HMS requirement
• 0.42 kg
• 833.1 cm3
• $47.60
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Crew Health Index
Current ISS Resources
Additional Resources
Mean = 48.8%
Median = 49.2%
95% Inference: (15 – 81%)
Mean = 59.4%
Median = 60.6%
95% Inference: (26 – 86%)
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24 Day vs. 33 Day Missions
• Does a 33 day lunar mission require a 
different level of care than a 24 day 
lunar mission?
Variable Mission 1 Mission 2
Mission length 24 Days 33 Days
# Crew 4 (3M, 1F) 4 (3M, 1F)
# EVAs/Person 4 5
Resources ISS ISS
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Total Medical Events
• Mean 18.3 21.0
• Median 18.0 21.0
• St. Dev. 3.6 4.0
• Minimum 4.0 5.0
• Maximum 33.0 38.0
• 95% Inference 12 - 26 13 - 29
24 Days 33 Days
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Sensitivity Analysis
• Headache (SAS)
• Nasal congestion (SAS)
• Space motion sickness (SAS)
• Insomnia (SAS)
• Back pain (SAS)
• Headache (SAS)
• Nasal congestion (SAS)
• Space motion sickness (SAS)
• Skin rash
• Late insomnia
24 Day Mission
33 Day Mission
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Crew Health Index
24 Day Mission
33 Day Mission
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Crew Health Index
• Mean 89.6% 89.0%
• Median 92.0% 91.6%
• St. Dev. 7.9% 8.4%
• Minimum 50.0% 26.8%
• Maximum 99.6% 99.7%
• 95% Inference 69.0-98.2% 66.9-98.1%
24 Days 33 Days
